TriageHF™ technology is a simplified, integrated heart failure risk assessment tool that alerts clinicians to clinically relevant changes in a patient’s status that may lead to a heart failure decompensation.
Watch the video to learn how to streamline your care of heart failure patients with TriageHF™ technology.
Today, there is not an automated mechanism to identify which implantable cardioverter defibrillator (ICD)/cardiac resynchronization therapy-defibrillator (CRT-D) patients are at the highest risk of heart failure decompensation.
TriageHF™† technology automates patient triage for clinicians to identify which patients are at the highest risk of heart failure decompensation.
TriageHF™ technology assesses a patient’s risk of heart failure: high, medium, or low.
Current workflows require a manual approach to identify high-risk patients. TriageHF™ technology offers a simplified and automated tool to easily identify patients at the highest risk of heart failure decompensation.
MyCareLink Relay™ home communicator, MyCareLink Heart™ mobile app, and MyCareLink™ patient monitor scheduled transmissions or CareAlert™ notifications are automatically sent to clinic.
Quickly sort high-, medium-, or low-risk heart failure patients.
or
Review TriageHF™ technology notifications for high-risk patients.
Review an automated and simple report displaying factors contributing to risk status
Phone: 800-505-4636
Cobalt™ CRT-Ds are used in heart failure (HF) management.
Cobalt™ ICDs are used to treat sudden cardiac arrest and abnormal heart rhythms.
Crome™ ICDs are used to treat sudden cardiac arrest and abnormal heart rhythms.
Crome™ CRT-Ds are used in heart failure (HF) management.
Percepta™ cardiac resynchronization therapy pacemakers (CRT-Ps) are enabled with BlueSync™ technology, allowing for tablet-based programming.
† TriageHF™ technology is not an alarm. The TriageHF™ assessment does not replace heart failure assessments in standard clinical practice. Medical treatment should not be modified remotely based solely on the TriageHF™ assessment. Interpretation of the TriageHF™ assessment requires clinical judgment by a medical professional. The TriageHF™ assessment should be used in conjunction with professional guidelines for patient management decisions.
‡ TriageHF™ technology requires clinic activation. Contact your local Medtronic sales representative for activation requirements.
